FDA Lists Impurity-Free Valsartan And Other ARB Drugs
Executive Summary
In the wake of impurities being discovered in certain valsartan and other ARB drugs, the FDA has published a list of known nitrosamine-free examples of these medicines as part of ongoing efforts to address the issue.
You may also be interested in...
Alembic Gets Sartans Shot In Q2
The continuing sartans crisis and new product launches in US helped Alembic to post a strong Q2 performance, despite slowdown in other markets.
Alembic Q2 Gets Sartans Shot
Continuing sartans crisis, new product launches in US help Alembic post strong Q2 performance despite slowdown in other markets.
NDMA In Ranitidine Risks Rerun Of Sartans Crisis
Regulators in North America and Europe are reacting to the discovery of the impurity NMDA in ranitidine, just over a year after similar impurities in sartan products led to a slew of recalls and withdrawals around the world.